Crossmark

[Translated article] High Efficacy of Dupilumab in Omalizumab-Refractory Severe Chronic Spontaneous Urticaria and Delayed Pressure Urticaria

Crossref DOI link: https://doi.org/10.1016/j.ad.2024.11.020

Published Print: 2025-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pastor-Nieto, M.A.

Gatica-Ortega, M.E.
License Information

Text and Data Mining valid from 2025-02-01

Text and Data Mining valid from 2025-02-01

Version of Record valid from 2024-11-15
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] High Efficacy of Dupilumab in Omalizumab-Refractory Severe Chronic Spontaneous Urticaria and Delayed Pressure Urticaria

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2024.11.020

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2023.07.038

Content Type: simple-article

Copyright: © 2024 AEDV. Published by Elsevier España, S.L.U.